Ralf Eschbach
Overview
Explore the profile of Ralf Eschbach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grawe F, Rosenberger N, Ingenerf M, Beyer L, Eschbach R, Todica A, et al.
Cancer Imaging
. 2023 Apr;
23(1):41.
PMID: 37098632
Background: The aim of this retrospective study was to compare the diagnostic accuracy of somatostatin receptor (SSR)-PET/CT to liver MRI as reference standard in the evaluation of hepatic involvement in...
2.
Grawe F, Ebner R, Geyer T, Beyer L, Winkelmann M, Sheikh G, et al.
Eur Radiol
. 2023 Mar;
33(5):3416-3424.
PMID: 36964768
Objectives: The recently proposed standardized reporting and data system for somatostatin receptor (SSTR)-targeted PET/CT SSTR-RADS 1.0 showed promising first results in the assessment of diagnosis and treatment planning with peptide...
3.
Kazmierczak P, Burian E, Eschbach R, Hirner-Eppeneder H, Moser M, Havla L, et al.
PLoS One
. 2015 Sep;
10(9):e0138452.
PMID: 26393949
Objective: To investigate annexin-based optical fluorescence imaging (OI) for monitoring regorafenib-induced early cell death in experimental colon carcinomas in rats, validated by perfusion MRI and multiparametric immunohistochemistry. Materials And Methods:...
4.
Sterzik A, Paprottka P, Zengel P, Hirner H, Rosspunt S, Eschbach R, et al.
Acta Radiol
. 2014 Mar;
56(3):294-303.
PMID: 24609871
Background: Novel anti-angiogenic treatments are increasingly complementing established cancer therapy strategies in head and neck tumors. Contrast-enhanced magnetic resonance imaging (MRI) can be applied for early and non-invasive therapy monitoring...
5.
Cyran C, Kazmierczak P, Hirner H, Moser M, Ingrisch M, Havla L, et al.
PLoS One
. 2013 Oct;
8(9):e76009.
PMID: 24098755
Objective: To investigate dynamic contrast-enhanced computed tomography for monitoring the effects of regorafenib on experimental colon carcinomas in rats by quantitative assessments of tumor microcirculation parameters with immunohistochemical validation. Materials...
6.
Cyran C, von Einem J, Paprottka P, Schwarz B, Ingrisch M, Dietrich O, et al.
Invest Radiol
. 2011 Sep;
47(1):49-57.
PMID: 21934514
Objectives: To investigate dynamic contrast-enhanced computed tomography (DCE-CT) for monitoring the effects of sorafenib on experimental prostate carcinomas in rats by quantitative assessments of tumor microcirculation parameters with immunohistochemical validation....